| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MTO1_0004600 | Exon-Exon | chr6:74190398-74207619 | chr6:73480675-73497896 | 161 nt | 0.4099 |
| hsa_MTO1_0004700 | Intron-Intron | chr6:74190955-74191218 | chr6:73481232-73481495 | 264 nt | 0.3030 |
| hsa_chr6_0619500 | Intergenic-Intergenic | chr6:74190966-74191229 | chr6:73481243-73481506 | 264 nt | 0.3068 |
| hsa_MTO1_0004900 | Exon-Exon | chr6:74191752-74192343 | chr6:73482029-73482620 | 216 nt | 0.5324 |
| hsa_MTO1_0004800 | Exon-Exon | chr6:74191752-74207619 | chr6:73482029-73497896 | 668 nt | 0.4461 |
| hsa_MTO1_0005000 | Exon-Exon | chr6:74191763-74192343 | chr6:73482040-73482620 | 377 nt | 0.4695 |
| hsa_MTO1_0005100 | Exon-Intron | chr6:74191763-74196484 | chr6:73482040-73486761 | 541 nt | 0.4787 |
| hsa_MTO1_0005200 | Exon-Exon | chr6:74191763-74202075 | chr6:73482040-73492352 | 291 nt | 0.4021 |
| hsa_chr6_0619600 | Intergenic-Intergenic | chr6:74191862-74192368 | chr6:73482139-73482645 | 303 nt | 0.4356 |
| hsa_MTO1_0005500 | Intron-Exon-Intron | chr6:74192172-74196484 | chr6:73482449-73486761 | 336 nt | 0.4435 |
A review consolidating existing research indicates that the circMTO1 functions as a tumor suppressor in hepatocellular carcinoma [Lee et al. DOI:10.1016/j.biopha.2018.12.052] and sponges miR-630 to reverse temozolomide chemoresistance in glioblastoma [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].